Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2004
09/23/2004WO2004080964A1 Indole derivatives useful for the treatment of diseases
09/23/2004WO2004080462A1 c-Kit KINASE INHIBITOR
09/23/2004WO2004064708A3 Solution for nostril wash
09/23/2004WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
09/23/2004WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
09/23/2004WO2004014293A3 Combination of anti-muscarinic agents and non-glucocorticoid steroids
09/23/2004WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds
09/23/2004WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer
09/23/2004WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto
09/23/2004US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents
09/23/2004US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors
09/23/2004US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia
09/23/2004US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/23/2004US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate
09/23/2004US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
09/23/2004US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents
09/23/2004US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/23/2004US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders
09/23/2004US20040186104 Novel pyridinone and related heterocyclic derivatives
09/23/2004US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis
09/23/2004US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering
09/23/2004US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma
09/23/2004US20040185500 Use of disease-associated gene
09/23/2004US20040185122 Selective COX-2 inhibition from edible plant extracts
09/23/2004US20040184993 allows the modulation of the mass median aerodynamic diameter of the aerosol particles on actuation of the inhaler to a value which is suited for the pulmonary administration
09/23/2004CA2517569A1 Indole derivatives useful for the treatment of diseases
09/22/2004EP1460066A1 Piperazine compounds
09/22/2004EP1460064A1 Indole-2-carboxamide derivatives useful as beta-2 agonists
09/22/2004EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use
09/22/2004EP1458864A1 Tgf-beta-specific covalently closed antisense molecule
09/22/2004EP1458752A2 Polypeptides of pseudomonas aeruginosa
09/22/2004EP1458746A2 Cyclic tetrapeptide compound and use thereof
09/22/2004EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
09/22/2004EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
09/22/2004EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
09/22/2004EP1458718A1 Quinolinones as prostaglandin receptor ligands
09/22/2004EP1458717A1 Aroyl pyridinones
09/22/2004EP1458715A1 Novel compounds
09/22/2004EP1458712A2 Novel compounds
09/22/2004EP1458706A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
09/22/2004EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof
09/22/2004EP1458682A1 1,4-dihydro-1,4-diphenylpyridine derivatives
09/22/2004EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators
09/22/2004EP1458676A2 Compounds for the treatment of inflammatory disorders
09/22/2004EP1458405A1 Use of fk506 and analogues for treating allergic diseases
09/22/2004EP1458397A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
09/22/2004EP1458392A2 Acridone inhibitors of impdh enzyme
09/22/2004EP1458387A2 Orodispersible tablets containing fexofenadine
09/22/2004EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/22/2004EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine
09/22/2004EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
09/22/2004EP1289505B1 Process of producing a stable pharmaceutical composition containing micronized formoterol
09/22/2004EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
09/22/2004EP1259495B1 Indane derivatives and their use as cell adhesion inhibitors
09/22/2004EP1242073B1 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use
09/22/2004EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases
09/22/2004EP1146874B1 Vitronectin receptor antagonist
09/22/2004EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists
09/22/2004EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
09/22/2004EP1100781B1 High affinity ligands for nociceptin receptor orl-1
09/22/2004EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
09/22/2004EP0841900B1 Pharmaceutical composition for detecting lung disease
09/22/2004EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
09/22/2004CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene
09/22/2004CN1531592A Process for preparation of neutrophil inhibitory factor
09/22/2004CN1531549A Pharmaceutical use for secreted bacterial effector proteins
09/22/2004CN1531546A Peptide compounds
09/22/2004CN1531536A Process for preparation of pyrazolo[4,3-D] pyrimidine derivative
09/22/2004CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
09/22/2004CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies
09/22/2004CN1531528A Dibenzocycloheptene compound
09/22/2004CN1531425A Urea derivatives as integrin alpha 4 antagonists
09/22/2004CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof
09/22/2004CN1530128A Chinese medicine preparation for treating acute and chronic pharyngitis, preparing method thereof
09/22/2004CN1530120A Preparing method for compound Rhododendron dauricum dropping pellet
09/22/2004CN1530097A Use of trivalency chromium in preparation of drug against allergic rhinitis
09/22/2004CN1167710C Pyrrolidincarbonylamino cyclic disulfides
09/22/2004CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors
09/22/2004CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d
09/22/2004CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha
09/22/2004CN1167466C Oral medicinal preparation
09/22/2004CN1167449C Medicine for nasosinusitis
09/22/2004CN1167448C Cough relieving medicated wine
09/22/2004CN1167445C Chinese herbal medicinal preparation for treating rhinitis and nasosinusitis
09/21/2004US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide
09/21/2004US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease
09/21/2004US6794416 Treatment of chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in humans that smoke or smoked cigarettes using aerosol or nebulizing device with or without concommitant treatment
09/21/2004US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia
09/21/2004US6794403 Substituted benzoxazoles as estrogenic agents
09/21/2004US6794391 Inhibitors of phosphodiesterase (pde) isoenzymes; useful for treatment of respiratory disorders such as asthma.
09/21/2004US6794386 β-amino acid compounds as integrin antagonists
09/21/2004US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof
09/21/2004US6794380 Amide derivatives
09/21/2004US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide
09/21/2004US6793936 Delivers an active ingredient in a pulsed or bimodal manner.
09/21/2004CA2146757C Stabilization of fluorocarbon emulsions
09/21/2004CA2100381C N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their preparation and pharmaceutical compositions containing the same
09/21/2004CA2076226C Substituted 1-pyrimidinylacetamide compounds
09/16/2004WO2004078756A2 Jnk inhibitors
09/16/2004WO2004078754A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors